DK1126859T3 - Blodleukocyt-aferese til behandling af HIV - Google Patents

Blodleukocyt-aferese til behandling af HIV

Info

Publication number
DK1126859T3
DK1126859T3 DK00905345T DK00905345T DK1126859T3 DK 1126859 T3 DK1126859 T3 DK 1126859T3 DK 00905345 T DK00905345 T DK 00905345T DK 00905345 T DK00905345 T DK 00905345T DK 1126859 T3 DK1126859 T3 DK 1126859T3
Authority
DK
Denmark
Prior art keywords
hiv
treatment
leucocytes
blood leukocyte
blood
Prior art date
Application number
DK00905345T
Other languages
Danish (da)
English (en)
Inventor
Masakazu Adachi
Toshifumi Hibi
Original Assignee
Jimro Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11072144A external-priority patent/JP2000262612A/ja
Application filed by Jimro Co Ltd filed Critical Jimro Co Ltd
Application granted granted Critical
Publication of DK1126859T3 publication Critical patent/DK1126859T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0439—White blood cells; Leucocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A61M2202/206—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00905345T 1999-03-17 2000-02-25 Blodleukocyt-aferese til behandling af HIV DK1126859T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11072144A JP2000262612A (ja) 1999-03-17 1999-03-17 Ｈｉｖ感染疾患の処置方法
GBGB9919565.3A GB9919565D0 (en) 1999-03-17 1999-08-18 Treatment of disease

Publications (1)

Publication Number Publication Date
DK1126859T3 true DK1126859T3 (da) 2006-08-28

Family

ID=26315857

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00905345T DK1126859T3 (da) 1999-03-17 2000-02-25 Blodleukocyt-aferese til behandling af HIV

Country Status (10)

Country Link
US (1) US6498007B1 (fr)
EP (1) EP1126859B1 (fr)
JP (1) JP4643830B2 (fr)
AT (1) ATE325613T1 (fr)
AU (1) AU2692900A (fr)
DE (1) DE60027863T2 (fr)
DK (1) DK1126859T3 (fr)
ES (1) ES2262506T3 (fr)
PT (1) PT1126859E (fr)
WO (1) WO2000055621A2 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020197249A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products
US8329388B2 (en) * 1997-07-30 2012-12-11 Cytosorbents, Inc. Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood
US20020159995A1 (en) * 1997-07-30 2002-10-31 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
US20020197250A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
US20020198487A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids
US20020197252A1 (en) * 2001-04-10 2002-12-26 Renal Tech International Selective adsorption devices and systems
US6878127B2 (en) 2001-04-10 2005-04-12 Renaltech International, Llc Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood
DE20121877U1 (de) * 2001-09-27 2003-09-18 LeukoCare GmbH, 85646 Neufarn Leukozyten-Inaktivierungs-Modul (LIM)
JP2003235959A (ja) * 2002-02-14 2003-08-26 Nippon Koutai Kenkyusho:Kk Ｃ型肝炎ウイルスの除去・減量方法
JP4925829B2 (ja) * 2004-08-30 2012-05-09 株式会社カネカ 顆粒球吸着材
WO2006028202A1 (fr) * 2004-09-10 2006-03-16 Kaneka Corporation Adsorbant pour inhibiteur de la prolifération des lymphocytes et procédé de traitement
JPWO2006106763A1 (ja) * 2005-03-30 2008-09-11 株式会社カネカ リンパ球増殖抑制因子の除去方法
KR100647335B1 (ko) 2005-04-15 2006-11-23 삼성전자주식회사 소수성 고체 지지체를 이용한 세포 분리 방법
EP1712284B1 (fr) * 2005-04-15 2012-10-10 Samsung Electronics Co., Ltd. Méthode de séparation de cellules comprenant l'utilisation de supports solides hydrophobes
CN101267850B (zh) 2005-09-09 2011-05-11 门布拉内有限公司 从血液中去除白细胞的方法
US20100135976A1 (en) * 2006-06-16 2010-06-03 Rune Nilsson Adsorption device
KR100813264B1 (ko) 2006-08-21 2008-03-13 삼성전자주식회사 비평면 형상의 고체 지지체를 이용하여 미생물로부터핵산을 증폭하는 방법
US8158411B2 (en) * 2006-08-21 2012-04-17 Samsung Electronics Co., Ltd. Method of separating microorganism using nonplanar solid substrate and device for separating microorganism using the same
JP2008048735A (ja) * 2006-08-21 2008-03-06 Samsung Electronics Co Ltd 非平面状の固体支持体を用いた微生物の分離方法及び分離装置
KR100917465B1 (ko) * 2006-08-21 2009-09-14 삼성전자주식회사 비평면 형상의 고체 지지체를 이용하여 미생물을 분리하는방법 및 미생물분리 장치
KR100813265B1 (ko) 2006-08-21 2008-03-13 삼성전자주식회사 비평면 형상의 고체 지지체를 이용하여 미생물로부터핵산을 증폭하는 방법
CA2664770C (fr) * 2006-09-29 2014-05-27 Toray Industries, Inc. Colonne adsorbeuse de cellules
KR101427609B1 (ko) * 2007-01-13 2014-08-07 멤브라나 게엠베하 혈액으로부터 백혈구를 제거하는 장치
EP2187957A4 (fr) 2007-08-31 2011-08-24 Univ Michigan Dispositifs permettant d'effectuer une cytaphérèse sélective et procédés associés
US20090149802A1 (en) * 2007-12-07 2009-06-11 Ross Peter Jones Surgical System Including a Trap for Noise-Inducing Materials
PH12012500702A1 (en) * 2009-10-08 2012-10-29 Otsuka Pharma Co Ltd An immunoactivation blood perfusion filter for the treatment of malignant tumors
US20130288370A1 (en) 2010-10-15 2013-10-31 Cytopherx, Inc. Cytopheresis cartridges and use thereof
DE102010049790A1 (de) * 2010-10-29 2012-05-03 Fresenius Medical Care Deutschland Gmbh Medizinische Trennvorrichtung
US20130068691A1 (en) * 2011-08-05 2013-03-21 Henry John Smith Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders
EP2606921A1 (fr) 2011-12-21 2013-06-26 Infomed SA Dispositif d'épuration du sang par circulation extracorporelle
CA2860831C (fr) 2012-01-09 2024-09-10 Seastar Medical, Inc. Cartouche et procede d'augmentation de la fonction myocardique
WO2014192908A1 (fr) * 2013-05-31 2014-12-04 東レ株式会社 Colonne garnie de porteur d'adsorption
EP3185926B1 (fr) 2014-08-26 2018-11-28 3M Innovative Properties Company Système d'élimination de médiateurs pro-inflammatoires et granulocytes et monocytes sanguins
US11383015B2 (en) * 2016-01-11 2022-07-12 Fenwal, Inc. System and method for plasma purification prior to mononuclear cell collection
CN106267410B (zh) * 2016-07-01 2019-03-08 翁炳焕 艾滋病感染细胞分离器
CN106166313B (zh) * 2016-07-01 2018-09-07 浙江大学 一种艾滋病孕妇血液净化器
CN106267414B (zh) * 2016-07-01 2019-02-19 翁炳焕 艾滋病免疫净化器
WO2019136289A1 (fr) 2018-01-05 2019-07-11 Path Ex, Inc. Dispositif pour la capture et l'élimination de matériel de maladie à partir de fluides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906742A (en) * 1986-07-31 1990-03-06 Whitehead Institute For Biomedical Research Encoding antigens of M. Leprae
JP2673567B2 (ja) 1987-12-10 1997-11-05 株式会社日本抗体研究所 血液中の顆粒球除去方法及びこれに用いる顆粒球除去装置
US5807881A (en) 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
US5567443A (en) * 1993-08-04 1996-10-22 Japan Immunoresearch Laboratories Co., Ltd. Method of treating inflammatory diseases
US5525279A (en) 1994-04-04 1996-06-11 Sekisui Kagaku Kogyo K.K. Method of forming a granulocyte adsorbing carrier and granulocyte remover

Also Published As

Publication number Publication date
DE60027863T2 (de) 2006-12-07
JP4643830B2 (ja) 2011-03-02
WO2000055621A3 (fr) 2001-04-19
WO2000055621A8 (fr) 2001-07-05
EP1126859A2 (fr) 2001-08-29
ATE325613T1 (de) 2006-06-15
EP1126859B1 (fr) 2006-05-10
WO2000055621A2 (fr) 2000-09-21
PT1126859E (pt) 2006-09-29
JP2002539178A (ja) 2002-11-19
ES2262506T3 (es) 2006-12-01
DE60027863D1 (de) 2006-06-14
AU2692900A (en) 2000-10-04
US6498007B1 (en) 2002-12-24

Similar Documents

Publication Publication Date Title
DK1126859T3 (da) Blodleukocyt-aferese til behandling af HIV
NO920834L (no) Fremgangsmaate for inaktivering av virus i blod og blodprodukter
EA200700243A1 (ru) Способы лечения гепатита с
AU580402B2 (en) Method of inactivating viruses involving adsorption on solid phase
WO2000062836A3 (fr) Procede pour retirer la beta-2-microglobuline contenue dans le sang
PY0111577A (es) Métodos y composiciones para el tratamiento del virus de la hepatitis c
AU1721801A (en) Method for the preparation of purified hcv rna by exosome separation
EP1109564A4 (fr) Procede d'elimination du sang de virus hiv et d'autres virus
UA66767C2 (uk) Інгібітори серин-протеаз, фармацевтична композиція, спосіб інгібування активності та спосіб лікування або профілактики вірусної інфекції гепатиту с
DE68915045D1 (de) Reinigung von Pertussis-Toxinen und Herstellung von Vakzine.
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
MD1507G2 (ro) Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
DE60142562D1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der unterdrückung von hepatitis virus infektion
WO2003002749A3 (fr) Procedes servant a detecter simultanement des antigenes de hcv et des anticorps anti-hcv
ATE516034T1 (de) Verfahren zur modulation der immunreaktion in einem infektierten säugetier mittels transmukosales eingeben eines modulationsmittel
AU2001232267A1 (en) Remedies for hepatitis c
EP1044696A3 (fr) Elimination des virus du sang, du plasma ou du sérum
ES2133780T3 (es) Procedimiento para recuperar polihidroxialcanoatos usando fraccionamiento centrifugo.
ES2140652T3 (es) Uso de n-alquil-derivados de 1,5-didesoxi-1,5-imino-d-glucitol para el tratamiento de infecciones por el virus de la hepatitis b.
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
ES2193210T3 (es) Separacion de virus de soluciones de proteinas por ultrafiltracion.
DE69906568D1 (de) Behandlung von hämorrhagischem virusfieber mit protein c
ES2113910T3 (es) Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus.
WO1990013281A3 (fr) Procede de suppression d'une infection par l'hiv
ATE526977T1 (de) Verfahren zur inaktivierung infektioeser erreger in biologischen flüssigkeiten